Genetic background of idiopathic pulmonary fibrosis

References

• Raghu G, Collard HR, Egan JJ et al.; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 183(6), 788–824 (2011).
   PubMed Web of Science ®Google Scholar
• Grutters JC, du Bois RM. Genetics of fibrosing lung diseases. Eur. Respir. J. 25(5), 915–927 (2005).
   PubMed Web of Science ®Google Scholar
• Castriotta RJ, Eldadah BA, Foster WM et al. Workshop on idiopathic pulmonary fibrosis in older adults. Chest 138(3), 693–703 (2010).
   PubMed Web of Science ®Google Scholar
• Meltzer EB, Noble PW. Idiopathic pulmonary fibrosis. Orphanet J. Rare Dis. 3, 8 (2008).
   PubMed Web of Science ®Google Scholar
• Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N. Engl. J. Med. 345(7), 517–525 (2001).
   PubMed Web of Science ®Google Scholar
• Baumgartner KB, Samet JM, Stidley CA, Colby TV, Waldron JA. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 155(1), 242–248 (1997).
   PubMed Web of Science ®Google Scholar
• Hubbard R, Lewis S, Richards K, Johnston I, Britton J. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 347(8997), 284–289 (1996).
   PubMed Web of Science ®Google Scholar
• Jakab GJ. Sequential virus infection, bacterial superinfections and fibrogenesis. Am Rev Respir. Dis. 142, 374–379 (1990).
   PubMed Web of Science ®Google Scholar
• Pinsker KL, Schneyer B, Becker N, Kamholz SL. Usual interstitial pneumonia following Texas A2 influenza infection. Chest 80(2), 123–126 (1981).
   PubMed Web of Science ®Google Scholar
• Bremer LA, Blackman SM, Vanscoy LL et al. Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis. Hum. Mol. Genet. 17(14), 2228–2237 (2008).
   PubMed Web of Science ®Google Scholar
• Vasakova M, Striz I, Slavcev A, Jandova S, Kolesar L, Sulc J. Th1/Th2 cytokine gene polymorphisms in patients with idiopathic pulmonary fibrosis. Tissue Antigens 67(3), 229–232 (2006).
   PubMedGoogle Scholar
• García-Sancho C, Buendía-Roldán I, Fernández-Plata MR et al. Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis. Respir. Med. 105(12), 1902–1907 (2011).
   PubMed Web of Science ®Google Scholar
• Weaver TE, Conkright JJ. Function of surfactant proteins B and C. Annu. Rev. Physiol. 63, 555–578 (2001).
   PubMed Web of Science ®Google Scholar
• Fisher JH, Emrie PA, Drabkin HA et al. The gene encoding the hydrophobic surfactant protein SP-C is located on 8p and identifies an EcoRI RFLP. Am. J. Hum. Genet. 43(4), 436–441 (1988).
   PubMed Web of Science ®Google Scholar
• Glasser SW, Korfhagen TR, Perme CM, Pilot-Matias TJ, Kister SE, Whitsett JA. Two SP-C genes encoding human pulmonary surfactant proteolipid. J. Biol. Chem. 263(21), 10326–10331 (1988).
   PubMed Web of Science ®Google Scholar
• Nogee LM, Dunbar AE 3rd, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N. Engl. J. Med. 344(8), 573–579 (2001).
   PubMed Web of Science ®Google Scholar
• Thomas AQ, Lane K, Phillips J 3rd et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am. J. Respir. Crit. Care Med. 165(9), 1322–1328 (2002).
   PubMed Web of Science ®Google Scholar
• Brasch F, Griese M, Tredano M et al. Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene. Eur. Respir. J. 24(1), 30–39 (2004).
   PubMed Web of Science ®Google Scholar
• van Moorsel CH, van Oosterhout MF, Barlo NP et al. Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort. Am. J. Respir. Crit. Care Med. 182(11), 1419–1425 (2010).
   PubMed Web of Science ®Google Scholar
• Lawson WE, Grant SW, Ambrosini V et al. Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax 59(11), 977–980 (2004).
   PubMed Web of Science ®Google Scholar
• Markart P, Ruppert C, Wygrecka M et al. Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias. Eur. Respir. J. 29(1), 134–137 (2007).
   PubMed Web of Science ®Google Scholar
• Selman M, Lin HM, Montaño M et al. Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum. Genet. 113(6), 542–550 (2003).
   PubMed Web of Science ®Google Scholar
• Wang Y, Kuan PJ, Xing C et al. Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am. J. Hum. Genet. 84(1), 52–59 (2009).
   PubMed Web of Science ®Google Scholar
• Shulenin S, Nogee LM, Annilo T, Wert SE, Whitsett JA, Dean M. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N. Engl. J. Med. 350(13), 1296–1303 (2004).
   PubMed Web of Science ®Google Scholar
• Bullard JE, Wert SE, Whitsett JA, Dean M, Nogee LM. ABCA3 mutations associated with pediatric interstitial lung disease. Am. J. Respir. Crit. Care Med. 172(8), 1026–1031 (2005).
   PubMed Web of Science ®Google Scholar
• Young LR, Nogee LM, Barnett B, Panos RJ, Colby TV, Deutsch GH. Usual interstitial pneumonia in an adolescent with ABCA3 mutations. Chest 134(1), 192–195 (2008).
   PubMed Web of Science ®Google Scholar
• Armanios MY, Chen JJ, Cogan JD et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med. 356(13), 1317–1326 (2007).
   PubMed Web of Science ®Google Scholar
• Tsakiri KD, Cronkhite JT, Kuan PJ et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc. Natl Acad. Sci. USA 104(18), 7552–7557 (2007).
   PubMed Web of Science ®Google Scholar
• Alder JK, Chen JJ, Lancaster L et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl Acad. Sci. USA 105(35), 13051–13056 (2008).
   PubMed Web of Science ®Google Scholar
• Mushiroda T, Wattanapokayakit S, Takahashi A et al.; Pirfenidone Clinical Study Group. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J. Med. Genet. 45(10), 654–656 (2008).
   PubMed Web of Science ®Google Scholar
• Hodgson U, Pulkkinen V, Dixon M et al. ELMOD2 is a candidate gene for familial idiopathic pulmonary fibrosis. Am. J. Hum. Genet. 79(1), 149–154 (2006).
   PubMed Web of Science ®Google Scholar
• Pulkkinen V, Bruce S, Rintahaka J et al. ELMOD2, a candidate gene for idiopathic pulmonary fibrosis, regulates antiviral responses. FASEB J. 24(4), 1167–1177 (2010).
   PubMed Web of Science ®Google Scholar
• Seibold MA, Wise AL, Speer MC et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N. Engl. J. Med. 364(16), 1503–1512 (2011).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Noth I, Garcia JG, Kaminski N. A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis. N. Engl. J. Med. 364(16), 1576–1577 (2011).
   PubMed Web of Science ®Google Scholar
• Hall FC, Bowness P. HLA and disease: From molecular function to disease association? In: HLA and MHC: Genes, Molecules, and Function. Browning MJ, McMichael AJ (Eds). BIOS Scientific Publishers Ltd, Oxford, UK, 353–381 (1996).
   Google Scholar
• de Bakker PI, McVean G, Sabeti PC et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat. Genet. 38(10), 1166–1172 (2006).
   PubMed Web of Science ®Google Scholar
• Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am. J. Respir. Crit. Care Med. 157(4 Pt 1), 1301–1315 (1998).
   PubMed Web of Science ®Google Scholar
• Stewart CA, Horton R, Allcock RJ et al. Complete MHC haplotype sequencing for common disease gene mapping. Genome Res. 14(6), 1176–1187 (2004).
   PubMed Web of Science ®Google Scholar
• Falfán-Valencia R, Camarena A, Juárez A et al. Major histocompatibility complex and alveolar epithelial apoptosis in idiopathic pulmonary fibrosis. Hum. Genet. 118(2), 235–244 (2005).
   PubMed Web of Science ®Google Scholar
• Aquino-Galvez A, Pérez-Rodríguez M, Camarena A et al. MICA polymorphisms and decreased expression of the MICA receptor NKG2D contribute to idiopathic pulmonary fibrosis susceptibility. Hum. Genet. 125(5-6), 639–648 (2009).
   PubMed Web of Science ®Google Scholar
• Xue J, Gochuico BR, Alawad AS et al. The HLA class II allele DRB1*1501 is over-represented in patients with idiopathic pulmonary fibrosis. PLoS ONE 6(2), e14715 (2011).
   Google Scholar
• Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-β 1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 122(1), 103–111 (1993).
   PubMed Web of Science ®Google Scholar
• Bartram U, Speer CP. The role of transforming growth factor β in lung development and disease. Chest 125(2), 754–765 (2004).
   PubMed Web of Science ®Google Scholar
• Willis BC, Liebler JM, Luby-Phelps K et al. Induction of epithelial–mesenchymal transition in alveolar epithelial cells by transforming growth factor-β1: potential role in idiopathic pulmonary fibrosis. Am. J. Pathol. 166(5), 1321–1332 (2005).
   PubMed Web of Science ®Google Scholar
• Khalil N, O’Connor RN, Unruh HW et al. Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 5(2), 155–162 (1991).
   PubMed Web of Science ®Google Scholar
• Santana A, Saxena B, Noble NA, Gold LI, Marshall BC. Increased expression of transforming growth factor β isoforms (β 1, β 2, β 3) in bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 13(1), 34–44 (1995).
   PubMed Web of Science ®Google Scholar
• Xaubet A, Marin-Arguedas A, Lario S et al. Transforming growth factor-β1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 168(4), 431–435 (2003).
   PubMed Web of Science ®Google Scholar
• Li XX, Li N, Ban CJ, Zhu M, Xiao B, Dai HP. Idiopathic pulmonary fibrosis in relation to gene polymorphisms of transforming growth factor-ß1 and plasminogen activator inhibitor 1. Chin. Med. J. 124(13), 1923–1927 (2011).
   PubMed Web of Science ®Google Scholar
• Mattei MG, Mattei JF, Bernard R, Giraud F. Partial trisomy 4 resulting from a complex maternal rearrangement of chromosomes 2, 4, and 18 with interstitial translocation. Hum. Genet. 51(1), 55–61 (1979).
   PubMed Web of Science ®Google Scholar
• Sadoshima J, Izumo S. Molecular characterization of angiotensin 2-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of AT1 receptor subtype. Circ. Res. 97, 1952–1959 (1993).
   Google Scholar
• Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, Baker KM. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ. Res. 72(6), 1245–1254 (1993).
   PubMed Web of Science ®Google Scholar
• Villarreal FJ, Kim NN, Ungab GD, Printz MP, Dillmann WH. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 88(6), 2849–2861 (1993).
   PubMed Web of Science ®Google Scholar
• Otsuka M, Takahashi H, Shiratori M, Chiba H, Abe S. Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist. Thorax 59(1), 31–38 (2004).
   PubMed Web of Science ®Google Scholar
• Nadrous HF, Ryu JH, Douglas WW, Decker PA, Olson EJ. Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis. Chest 126(2), 438–446 (2004).
   PubMed Web of Science ®Google Scholar
• Cambien F, Alhenc-Gelas F, Herbeth B et al. Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study. Am. J. Hum. Genet. 43(5), 774–780 (1988).
   PubMed Web of Science ®Google Scholar
• Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86(4), 1343–1346 (1990).
   PubMed Web of Science ®Google Scholar
• Fatini C, Gensini F, Sticchi E et al. High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. Am. J. Med. 112(7), 540–544 (2002).
   PubMed Web of Science ®Google Scholar
• Morrison CD, Papp AC, Hejmanowski AQ, Addis VM, Prior TW. Increased D allele frequency of the angiotensin-converting enzyme gene in pulmonary fibrosis. Hum. Pathol. 32(5), 521–528 (2001).
   PubMed Web of Science ®Google Scholar
• Li X, Molina-Molina M, Abdul-Hafez A, Uhal V, Xaubet A, Uhal BD. Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 295(1), L178–L185 (2008).
   PubMed Web of Science ®Google Scholar
• Whyte M, Hubbard R, Meliconi R et al. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-α gene polymorphisms. Am. J. Respir. Crit. Care Med. 162(2 Pt 1), 755–758 (2000).
   PubMed Web of Science ®Google Scholar
• Hutyrová B, Pantelidis P, Drábek J et al. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 165(2), 148–151 (2002).
   PubMed Web of Science ®Google Scholar
• du Bois RM. The genetic predisposition to interstitial lung disease: functional relevance. Chest 121(Suppl. 3), 14S–20S (2002).
   Web of Science ®Google Scholar
• Pantelidis P, Fanning GC, Wells AU, Welsh KI, Du Bois RM. Analysis of tumor necrosis factor-α, lymphotoxin-α, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 163(6), 1432–1436 (2001).
   PubMed Web of Science ®Google Scholar
• Whittington HA, Freeburn RW, Godinho SI, Egan J, Haider Y, Millar AB. Analysis of an IL-10 polymorphism in idiopathic pulmonary fibrosis. Genes Immun. 4(4), 258–264 (2003).
   PubMed Web of Science ®Google Scholar
• Vasakova M, Striz I, Slavcev A, Jandova S, Kolesar L, Scand J. Th1/ Th2 cytokine gene polymorphisms in patients with idiopathic pulmonary fibrosis. Immunol. 65, 265–270 (2007).
   Web of Science ®Google Scholar
• Vasakova M, Striz I, Slavcev A et al. Correlation of IL-1α and IL-4 gene polymorphisms and clinical parameters in idiopathic pulmonary fibrosis. Clin. Exp. Immunol. 166, 346–351 (2011).
   PubMed Web of Science ®Google Scholar
• Barlo NP, van Moorsel CH, Korthagen NM et al. Genetic variability in the IL1RN gene and the balance between interleukin (IL)-1 receptor agonist and IL-1ß in idiopathic pulmonary fibrosis. Clin. Exp. Immunol. 166(3), 346–351 (2011).
   PubMed Web of Science ®Google Scholar
• Korthagen NM, van Moorsel CH, Kazemier KM, Ruven HJ, Grutters JC. IL1RN genetic variations and risk of IPF: a meta-analysis and mRNA expression study. Immunogenetics 64(5), 371–377 (2012).
   PubMed Web of Science ®Google Scholar
• Southcott AM, Jones KP, Li D et al. Interleukin-8. Differential expression in lone fibrosing alveolitis and systemic sclerosis. Am. J. Respir. Crit. Care Med. 151(5), 1604–1612 (1995).
   PubMed Web of Science ®Google Scholar
• Keane MP, Belperio JA, Moore TA et al. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J. Immunol. 162(9), 5511–5518 (1999).
   PubMed Web of Science ®Google Scholar
• Mukaida N, Shiroo M, Matsushima K. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J. Immunol. 143(4), 1366–1371 (1989).
   PubMed Web of Science ®Google Scholar
• Hillian AD, Londono D, Dunn JM et al.; CF Gene Modifier Study Group. Modulation of cystic fibrosis lung disease by variants in interleukin-8. Genes Immun. 9(6), 501–508 (2008).
   PubMed Web of Science ®Google Scholar
• Renzoni E, Lympany P, Sestini P et al. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthritis Rheum. 43(7), 1633–1640 (2000).
   PubMedGoogle Scholar
• Ahn MH, Park BL, Lee SH et al. A promoter SNP rs4073T>A in the common allele of the interleukin 8 gene is associated with the development of idiopathic pulmonary fibrosis via the IL-8 protein enhancing mode. Respir. Res. 12, 73 (2011).
   PubMed Web of Science ®Google Scholar
• Zorzetto M, Bombieri C, Ferrarotti I et al. Complement receptor 1 gene polymorphisms in sarcoidosis. Am. J. Respir. Cell Mol. Biol. 27(1), 17–23 (2002).
   PubMed Web of Science ®Google Scholar
• Kubistova Z, Mrazek F, Lympany PA et al. The CR1 C5507G polymorphism is not involved in susceptibility to idiopathic pulmonary fibrosis in two European populations. Tissue Antigens 72(5), 483–486 (2008).
   PubMedGoogle Scholar
• Yuan YD, Zhao MX, Yu J. Association between genetic polymorphism of erythrocyte CR1 and the susceptibility of idiopathic pulmonary fibrosis. 34, 841–845 (2011).
   Google Scholar
• Bournazos S, Woof JM, Hart SP, Dransfield I. Functional and clinical consequences of Fc receptor polymorphic and copy number variants. Clin. Exp. Immunol. 157(2), 244–254 (2009).
   PubMed Web of Science ®Google Scholar
• Bournazos S, Grinfeld J, Alexander KM et al. Association of FcgRIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression. BMC Pulm. Med. 10, 51 (2010).
   PubMedGoogle Scholar
• Woessner JF Jr. The family of matrix metalloproteinase family. Ann. NY Acad. Sci. 732, 11–21 (1994).
   PubMed Web of Science ®Google Scholar
• Rutter JL, Mitchell TI, Butticè G et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 58(23), 5321–5325 (1998).
   PubMed Web of Science ®Google Scholar
• Checa M, Ruiz V, Montaño M, Velázquez-Cruz R, Selman M, Pardo A. MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis. Hum. Genet. 124(5), 465–472 (2008).
   PubMed Web of Science ®Google Scholar
• Zuo F, Kaminski N, Eugui E et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc. Natl Acad. Sci. USA 99(9), 6292–6297 (2002).
   PubMed Web of Science ®Google Scholar
• Kaminski N. Microarray analysis of idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 29(Suppl. 3), S32–S36 (2003).
   PubMed Web of Science ®Google Scholar
• Selman M, Ruiz V, Cabrera S et al. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? Am. J. Physiol. Lung Cell Mol. Physiol. 279(3), L562–L574 (2000).
   PubMed Web of Science ®Google Scholar
• Lemjabbar H, Gosset P, Lechapt-Zalcman E et al. Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: effects of steroid and immunosuppressive treatment. Am. J. Respir. Cell Mol. Biol. 20(5), 903–913 (1999).
   PubMed Web of Science ®Google Scholar
• Swiderski RE, Dencoff JE, Floerchinger CS, Shapiro SD, Hunninghake GW. Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 152(3), 821–828 (1998).
   PubMed Web of Science ®Google Scholar
• Ramos C, Montaño M, García-Alvarez J et al. Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am. J. Respir. Cell Mol. Biol. 24(5), 591–598 (2001).
   PubMed Web of Science ®Google Scholar
• Wei LQ, Dong Y, Li ZH. [Effect of atorvastatin on MMP-9 and TIMP-1 levels in bronchoalveolar lavage fluid and serum of rats with bleomycin-induced pulmonary fibrosis]. Zhejiang Da Xue Xue Bao Yi Xue Ban 40(1), 64–70 (2011).
   Google Scholar
• Ginsburg D, Zeheb R, Yang AY et al. cDNA cloning of human plasminogen activator-inhibitor from endothelial cells. J. Clin. Invest. 78(6), 1673–1680 (1986).
   PubMed Web of Science ®Google Scholar
• Mehta R, Shapiro AD. Plasminogen activator inhibitor type 1 deficiency. Haemophilia 14(6), 1255–1260 (2008).
   PubMed Web of Science ®Google Scholar
• Harold A. Disorders of lung matrix remodeling. J. Clin. Invest. 113, 148–157 (2004).
   PubMed Web of Science ®Google Scholar
• Fujii M, Hayakawa H, Urano T et al. Relevance of tissue factor and tissue factor pathway inhibitor for hypercoagulable state in the lungs of patients with idiopathic pulmonary fibrosis. Thromb. Res. 99(2), 111–117 (2000).
   PubMed Web of Science ®Google Scholar
• Kotani I, Sato A, Hayakawa H, Urano T, Takada Y, Takada A. Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. Thromb. Res. 77(6), 493–504 (1995).
   PubMed Web of Science ®Google Scholar
• Henry M, Tregouët DA, Alessi MC et al. Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort. Arterioscler. Thromb. Vasc. Biol. 18(1), 84–91 (1998).
   PubMed Web of Science ®Google Scholar
• Johanna GB, Michiel LB, Frits H, Cornelis K, Diederick EG. The 4G5G plymorphism in the gene for PAI-1 and the circadian oscillation of plasma PAI-1. Blood 101, 1841–1844 (2003).
   PubMed Web of Science ®Google Scholar
• Kim KK, Flaherty KR, Long Q et al. A plasminogen activator inhibitor-1 promoter polymorphism and idiopathic interstitial pneumonia. Mol. Med. 9(1–2), 52–56 (2003).
   PubMed Web of Science ®Google Scholar
• Lau NC, Lim LP, Weinstein EG, Bartel DP. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294(5543), 858–862 (2001).
   PubMed Web of Science ®Google Scholar
• Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br. J. Cancer 94(6), 776–780 (2006).
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2), 281–297 (2004).
   PubMed Web of Science ®Google Scholar
• Pandit KV, Corcoran D, Yousef H et al. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 182(2), 220–229 (2010).
   PubMed Web of Science ®Google Scholar
• Kass DJ, Kaminski N. Evolving genomic approaches to idiophatic pulmonary fibrosis: moving beyond genes. Clin. Transl. Sci. 4, 372–379 (2011).
   PubMed Web of Science ®Google Scholar
• Liu G, Friggeri A, Yang Y et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J. Exp. Med. 207(8), 1589–1597 (2010).
   PubMed Web of Science ®Google Scholar
• Cushing L, Kuang PP, Qian J et al. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 45(2), 287–294 (2011).
   PubMed Web of Science ®Google Scholar
• Rabinovich EI, Kapetanaki MG, Steinfeld I et al. Global methylation patterns in idiopathic pulmonary fibrosis. PLoS ONE 7(4), e33770 (2012).
   PubMed Web of Science ®Google Scholar
• Sanders YY, Ambalavanan N, Halloran B et al. Altered DNA methylation profile in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 186(6), 525–535 (2012).
   PubMed Web of Science ®Google Scholar
• Lawson WE, Loyd JE, Degryse AL. Genetics in pulmonary fibrosis–familial cases provide clues to the pathogenesis of idiopathic pulmonary fibrosis. Am. J. Med. Sci. 341(6), 439–443 (2011).
   PubMed Web of Science ®Google Scholar
• Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am. J. Respir. Crit. Care Med. 150(4), 967–972 (1994).
   PubMed Web of Science ®Google Scholar
• Ju W, Kim JW, Park NH et al. Matrix metalloproteinase-1 promoter polymorphism and epithelial ovarian cancer: does ethnicity matter? J. Obstet. Gynaecol. Res. 33(2), 155–160 (2007).
   PubMed Web of Science ®Google Scholar
• Botto M, Theodoridis E, Thompson EM et al. Fc gamma RIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease. Clin. Exp. Immunol. 104(2), 264–268 (1996).
   PubMed Web of Science ®Google Scholar
• Chen JY, Wang CM, Wu JM, Ho HH, Luo SF. Association of rheumatoid factor production with FcgammaRIIIa polymorphism in Taiwanese rheumatoid arthritis. Clin. Exp. Immunol. 144(1), 10–16 (2006).
   PubMed Web of Science ®Google Scholar
• Vij R, Noth I. Peripheral blood biomarkers in idiopathic pulmonary fibrosis. Transl. Res. 159(4), 218–227 (2012).
   PubMed Web of Science ®Google Scholar
• Couch FJ, Weber BL. Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core. Hum. Mutat. 8(1), 8–18 (1996).
   PubMed Web of Science ®Google Scholar
• Dakhlallah D, Batte K, Wang Y et al. Epigenetic regulation of miR-17~92 contributes to the pathogenesis of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 187(4), 397–405 (2013).
   PubMed Web of Science ®Google Scholar
• Hagaman JT, Kinder BW, Eckman MH. Thiopurine S- methyltransferase [corrected] testing in idiopathic pulmonary fibrosis: a pharmacogenetic cost-effectiveness analysis. Lung 188(2), 125–132 (2010).
   PubMed Web of Science ®Google Scholar
• Center DM, Schwartz DA, Solway J et al. Genomic medicine and lung diseases. Am. J. Respir. Crit. Care Med. 186(3), 280–285 (2012).
   PubMed Web of Science ®Google Scholar